Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.57 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | GPR84 | Q9NQS5 | 4/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | PGD | P52209 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | HMGCR | P04035 | 1/20 | 0.35 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.35 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.35 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18538667 | 1.00 | SLC22A6 (0.57) | SLC22A6MAPTGABRR1LMNAGPR84 | |
| SCHEMBL607504 | 1.00 | SLC22A6 (0.57) | SLC22A6MAPTGABRR1LMNAGPR84 | |
| SCHEMBL3409902 | 0.89 | SLC22A6 (0.50) | SLC22A6MAPTGABRR1LMNAGPR84 | |
| SCHEMBL6556987 | 0.83 | SLC22A6 (0.55) | SLC22A6MAPTGABRR1LMNAGPR84 | |
| SCHEMBL12348844 | 0.80 | ALDH1A1 (0.42) | SLC22A6PGDTDP1 | |
| SCHEMBL20621110 | 0.80 | FOLH1 (0.50) | SLC22A6MAPTGABRR1LMNASMN1; SMN2 | |
| SCHEMBL17206402 | 0.80 | ALDH1A1 (0.42) | SLC22A6PGDTDP1 | |
| SCHEMBL6465879 | 0.76 | SLC22A6 (0.52) | SLC22A6MAPTGABRR1LMNAGPR84 | |
| SCHEMBL10034514 | 0.76 | — | — | |
| SCHEMBL26138089 | 0.75 | SLC22A6 (0.75) | SLC22A6MAPTGABRR1LMNAGPR84 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1981831-A2 | KIT FOR AUTOMATED RESOLVING AGENT SELECTION AND METHOD THEREOF | Vaidya, Niteen A. (US) | 2008-10-22 | — | — | EP | claimed |
| WO-2007092264-A2 | KIT FOR AUTOMATED RESOLVING AGENT SELECTION AND METHOD THEREOF | VAIDYA NITEEN A (US) | 2007-08-16 | — | — | WO | claimed |
| EP-1469816-A2 | REDUCTION OF HAIR GROWTH | THE GILLETTE COMPANY (US) | 2004-10-27 | — | — | EP | claimed |
| US-20040198821-A1 | Reduction of hair growth | GILLETTE COMPANY, THE | 2004-10-07 | — | — | US | claimed |
| US-20040131568-A1 | Topical applying a fatty acid metabolism inhibitor; adriamycin, mercaptopropionic acid | GILLETTE COMPANY, THE | 2004-07-08 | — | — | US | claimed |
| US-20030202950-A1 | Reduction of hair growth | THE GILLETTE COMPANY | 2003-10-30 | — | — | US | claimed |
| US-20030153619-A1 | Applying on the skin, inhibiting fatty acid metabolism, using adriamycin, or enzyme inhibitors, dermatology | GILLETTE COMPANY, THE | 2003-08-14 | — | — | US | claimed |
| WO-2003063810-A2 | REDUCTION OF HAIR GROWTH | THE GILLETTE COMPANY (US) | 2003-08-07 | — | — | WO | claimed |
| US-11639347-B2 | Modulators of ATP-binding cassette transporters | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2023-05-02 | — | — | US | disclosed |
| CN-110724055-B | Preparation method of n-butyl 2,2, 4-trimethyl-3-hydroxypentanoate, latex paint and preparation method thereof | 润泰化学（泰兴）有限公司 | 2022-05-03 | — | — | CN | disclosed |
| US-20180216113-A1 | METHODS FOR REDUCING PROTEOTOXICITY | UNIV CALIFORNIA (US) | 2018-08-02 | — | — | US | disclosed |
| US-10022352-B2 | Modulators of ATP-binding cassette transporters | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2018-07-17 | — | — | US | disclosed |
| US-20180162842-A1 | MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS | VERTEX PHARMACEUTICALS INCORPORATED | 2018-06-14 | — | — | US | disclosed |
| WO-2017031330-A1 | METHODS FOR REDUCING PROTEOTOXICITY | THE REGENTS OF THE UNIVERSITY OF CALIFORNA (US) | 2017-02-23 | — | — | WO | disclosed |
| WO-2004005557-A1 | METAL COMPOUND REMOVAL | ENGELHARD CORPORATION (US) | 2004-01-15 | — | — | WO | disclosed |
| US-20030225301-A1 | Process for producing optically active 3-halogenocarboxylic acid ester and 3-azidocarboxylic acid ester | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2003-12-04 | — | — | US | disclosed |
| US-20030202950-A1 | Reduction of hair growth | THE GILLETTE COMPANY | 2003-10-30 | — | — | US | disclosed |
| EP-1344763-A1 | Process for producing optically active 3-halogenocarboxylic acid esters and 3-azide-carboxylic acid esters | Takasago International Corporation (JP) | 2003-09-17 | — | — | EP | disclosed |
| US-20030153619-A1 | Applying on the skin, inhibiting fatty acid metabolism, using adriamycin, or enzyme inhibitors, dermatology | GILLETTE COMPANY, THE | 2003-08-14 | — | — | US | disclosed |
| WO-2003063810-A2 | REDUCTION OF HAIR GROWTH | THE GILLETTE COMPANY (US) | 2003-08-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030225301-A1 | Process for producing optically active 3-halogenocarboxylic acid ester and 3-azidocarboxylic acid ester | HDHD5, APEH, AOC3 | SLC22A6 1264/4885MAPT 4347/4885GABRR1 3460/4885 |
| US-11639347-B2 | Modulators of ATP-binding cassette transporters | CFTR, ABCB1, ABCC2 | SLC22A6 84/4885MAPT 4484/4885GABRR1 1022/4885 |
| US-20180162842-A1 | MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS | CFTR, ABCB1, ABCC2 | SLC22A6 84/4885MAPT 4484/4885GABRR1 1022/4885 |
| US-10022352-B2 | Modulators of ATP-binding cassette transporters | CFTR, ABCB1, ABCC2 | SLC22A6 84/4885MAPT 4484/4885GABRR1 1022/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.